MAPT and Alzheimer disease: It remains a matter of debate, if the associations between the ApoE4 genotype and CSF concentrations of total tau and or phosphorylated tau protein concentrations and the progression of cognitive decline are of similar magnitude and validity as the association between the ApoE4 genotype and CSF concentrations of Aβ42 in AD.